Evidence map›Paper›PMID 41113612›Full record

ArticleFrontiers in allergy2025

Case Report: Not all recurrent "idiopathic" anaphylaxis is idiopathic.

Sally Mahgoub Khalil, Sherin Rahim, Hassan Mobayed, Maryam Ali Al-Nesf, Sami Bahna

Abstract readCase Reports
In one paragraph

Article in Frontiers in allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sally Mahgoub KhalilAllergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Sherin RahimAllergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Hassan MobayedAllergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Maryam Ali Al-NesfAllergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Sami BahnaAllergy and Immunology Division, Louisiana State University Health Sciences Center, Shreveport, LA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Anaphylaxis is the most severe manifestation of systemic immediate hypersensitivity, yet the underlying trigger often remains elusive. When routine history and allergy testing fail to identify a cause, the condition is classified as idiopathic anaphylaxis. Food additives, although uncommon culprits, may be overlooked, particularly in atopic individuals. Methods: We report a case of a 39-year-old woman with recurrent anaphylaxis initially diagnosed as idiopathic. Standard allergy testing, including extended skin prick and specific IgE panels, was negative. Due to a temporal association with restaurant-prepared food, an additive hypersensitivity was suspected. A detailed dietary history and targeted skin prick testing were employed using both commercial and in-house preparations of food colorants. Results: SPT was positive for carmine-containing red food colorants, including a commercially available gel and a prepared cochineal extract. Control subjects tested negative. sIgE to carmine was equivocal. The patient was educated about allergen avoidance and has remained symptom-free following elimination of carmine from her diet, cosmetics, and medications. Conclusion: This case underscores the importance of considering food additives, particularly carmine, in patients with unexplained anaphylaxis. Structured re-evaluation, patient-guided dietary review, and custom allergen testing may be essential in identifying hidden allergens. Clinicians should be vigilant about uncommon triggers when routine investigations fail to identify the cause.

Indexed as

anaphylaxiscarmine (E 120)food additivefood coloridiopathic anaphylaxis

Identifiers

PMID41113612
PMCPMC12528176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.